Clinical Trial Update: TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating TARCEVA (erlotinib) in combination with chemoradiation for patients with stage IIIA/B non-small cell lung cancer has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Non-Small Cell Lung Cancer, Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-11-20